Introduction: According to Mali’s National Immunization Center,
theHaemophilus
influenzae b (Hib) vaccine
coverage rate was 90% in 2015. Our work aimed to study invasive
bacterial infections due to Haemophilus influenzae type b in children
aged 0- 15 years hospitalized in the pediatrics department of the UH-GT. Method: We carried out a retrospective
descriptive study from January 2017 to December 2018 (i.e.
2 years) among children aged 0-15 years and hospitalized
for Haemophilus influenzae type b infection confirmed by culture (blood
culture, Cerebro-spinal Fluid, and pleural and skin fluid).Results: Thirty-three cases of Hib
infections were collected giving a frequency
of 0.2% and the age group 3 months to 3 years was the most affected
(72.73%).Children who received no vaccine accounted for
21.21%.
References
[1]
Bärnighausen, T., Bloom, D.E., Canning, D., Friedman, A., Levine, O.S., O’Brien, J., Privor-Dumm, L. and Walker, D. (2011) Rethinking the Benefits and Costs of Childhood Vaccination: The Example of the Haemophilus influenzae Type B Vaccine. Vaccine, 29, 2371-2380. https://doi.org/10.1016/j.vaccine.2010.11.090
[2]
World Health Organization (2017) Vaccination, Vaccins et Produits Biologiques.
https://www.who.int/immunization/policy/Immunization_routine
[3]
Booy, R., Hodgson, S., Carpenter, L., Mayon-White, R.T., Slack, M.P., Macfarlane, J.A., et al. (1994) Efficacy of Haemophilus influenzae Type B Conjugate Vaccine PRP-T. Lancet, 344, 362-366. https://doi.org/10.1016/S0140-6736(94)91400-1
[4]
Peltola, H. (2000) Worldwide Haemophilus influenzae Type B Disease at the beginning of the 21st Century: Global Analysis of the Disease Burden 25 Years after the Use of the Polysaccharide Vaccine and a Decade after the Advent of Conjugates. Clinical Microbiology Reviews, 13, 302-317.
https://doi.org/10.1128/CMR.13.2.302
[5]
Sow, S.O., Diallo, S., Campbell, J.D., Tapia, M.D., Keita, T., Keita, M.M., et al. (2005) Burden of Invasive Disease Caused by Haemophilus influenzae Type B in Bamako, Mali: Impetus for Routine Infant Immunization with Conjugate Vaccine. The Pediatric Infectious Disease Journal, 24, 533-537.
https://doi.org/10.1097/01.inf.0000164768.28135.0d
[6]
Sow, S.O., Tapia, M.D., Diallo, S., Keita, M.M., Sylla, M., Onwuchekwa, U., et al. (2009) Haemophilus influenza Type B Conjugate Vaccine Introduction in Mali: Impact on Disease Burden and Serologic Correlate of Protection. American Journal of Tropical Medicine and Hygiene, 80, 1033-1038.
https://doi.org/10.4269/ajtmh.2009.80.1033
[7]
Programme Elargide Vaccination(PEV) (2016) du Mali MSHP MARS 2016. Equipe. Section Immunisation/DNS.
http://www.sante.gov.ml/index.php/actualites/communiques/item/download/313_76379ed9011 d9fe8c3b7f2d8baa8c754
[8]
Zareia, A.E., Linjawic, M.H. and Redwana, E.M. (2016) Circulating Anti-Haemophilus influenzae Type B, Antibodies Contributing to Direct and Herd Immunity. Wulfenia Journal, 23, 22-55.
[9]
McCormick, D.W. and Molyneux, E.M. (2011) Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi. Emerging Infectious Diseases,17, 668-690. https://dx.doi.org/10.3201/eid1704.101045
[10]
Kabore, N.F., Poda, G.A., Barro, M., Cessouma, R., Hema, A., Ouedraogo, A.S., Sawadogo, A.B. and Nacro, B. (2012) Impact de la vaccination sur les admissions pour méningites à Haemophilus influenzae b de 2004 à 2008, à Bobo Dioulasso (Burkina Faso). Médecine et Santé Tropicales, 22, 425-429.
https://www.jle.com/10.1684/mst.2012.0122
[11]
Renner, L.A., Newman, M.J., Ahadzie, L., Antwi-Agyei, K.O. and Eshetu, M. (2007) Introduction of Haemophilus influenzae Type B Conjugate Vaccine into Routine Immunization in Ghana and Its Impact on Bacterial Meningitis in Children Younger than Five Years. The Pediatric Infectious Disease Journal, 26, 356-358.
https://doi.org/10.1097/01.inf.0000258693.19247.8e
[12]
Cisse, M.F, Breugelmans,G.J., Ba, M., Diop, M.B., Faye, P.C., Mhlanga, B., et al. (2010) The Elimination of Haemophilus influenzae Type B Meningitis Following Conjugate Vaccine Introduction in Senegal. Vaccine Impact in Senegal. The Pediatric Infectious Disease Journal, 29, 499-503.
https://doi.org/10.1097/INF.0b013e3181ccb0a0
[13]
Aujard, Y. (1999) Méningites purulentes du nouveau-né, du nourrisson, et de l’enfant. In Manuel du. Généraliste. Encyclo Méd chir, AKOS Encyclopédie Pratique de Pédiatrie, 8-0770, Elsevier, Paris, 5 p.
[14]
Diawara, A., Sangho, H., Sissoko, M., Bougoudogo, F. and Doumbo, O. (2008) Haemophilus influenzae Type B parmi les méningites bactériennes à Bamako (2002-2004). Mali Medical, 23, 43-46.
[15]
Camara, B., Faye, F.M., Diouf, S., Gueye-Diagne, N.-R., Diagne, I., Cissé, M.-F., et al. (2007) Méningite pédiatrique à Haemophilus influenzae b à Dakar. Médecine et Maladies Infectieuses, 37, 753-757. https://doi.org/10.1016/j.medmal.2007.03.002
[16]
Pablo, C.R., Alejandro, D.F., Jorge, C.A. and Marcela, L.H. (2006) Infections Invasives dues àHaemophilus influenzae detype b aprèsl’incorporation du vaccin conjugué dans le programme élargi de vaccination au Chili. Rev Chil Infect, 23, 50-54.
[17]
Scheifele, D., Halperin, S., Law, B. and King, A. (2005) Invasive Haemophilus influenzae Type B Infections in Vaccinated and Unvaccinated Children in Canada, 2001-2003. Canadian Medical Association Journal, 172, 53-56.
https://doi.org/10.1503/cmaj.1031861
[18]
Pedersen, T.I., Howitz, M. and Ostergaard, C. (2010) Clinical Characteristics of Haemophilus influenzae Meningitis in Denmark in the Post-Vaccination Era. Clinical Microbiology and Infection, 16, 439-446.
https://doi.org/10.1111/j.1469-0691.2009.02841.x
[19]
Tall, F., Elola, A., Sanou, I., et al. (2006) Méningite à Haemophilus et immunité naturelle anti-Haemophilus influenzae type b (Hib) chez les enfants au Burkina Faso. The Pediatric Infectious Disease Journal, 25, 415-419.
